US Stock MarketDetailed Quotes

MDNAF Medicenna Therapeutics

Watchlist
  • 1.057
  • -0.004-0.33%
15min DelayClose Nov 21 16:00 ET
80.79MMarket Cap-3886P/E (TTM)

Medicenna Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
20.31%35.63M
-49.45%16.98M
-49.45%16.98M
-39.82%21.76M
-35.80%25.69M
53.42%29.62M
63.60%33.6M
63.60%33.6M
54.55%36.15M
49.91%40.01M
-Cash and cash equivalents
20.31%35.63M
-49.45%16.98M
-49.45%16.98M
-39.82%21.76M
-35.80%25.69M
53.42%29.62M
63.60%33.6M
63.60%33.6M
54.55%36.15M
139.73%40.01M
Receivables
42.75%1.19M
36.14%1.16M
36.14%1.16M
125.14%403K
105.37%306K
788.30%835K
-34.63%855K
-34.63%855K
-70.36%179K
-65.35%149K
-Taxes receivable
--1.19M
36.14%1.16M
36.14%1.16M
----
----
----
-34.63%855K
-34.63%855K
----
----
-Other receivables
----
----
----
125.14%403K
105.37%306K
788.30%835K
----
----
-70.36%179K
-65.35%149K
Prepaid assets
8.20%1.12M
-51.86%931K
-51.86%931K
-41.07%1.05M
-27.70%1.69M
52.80%1.04M
24.94%1.93M
24.94%1.93M
-12.66%1.78M
-19.09%2.34M
Total current assets
20.50%37.94M
-47.57%19.08M
-47.57%19.08M
-39.10%23.21M
-34.86%27.68M
56.84%31.49M
55.55%36.39M
55.55%36.39M
46.39%38.11M
41.61%42.5M
Non current assets
Net PPE
--28K
----
----
----
----
----
----
----
----
----
Goodwill and other intangible assets
-8.33%55K
-6.56%57K
-6.56%57K
-6.45%58K
-6.35%59K
-7.69%60K
-6.15%61K
-6.15%61K
-8.82%62K
-8.70%63K
-Other intangible assets
----
----
----
----
--59K
--60K
----
----
----
----
Total non current assets
38.33%83K
-6.56%57K
-6.56%57K
-6.45%58K
-6.35%59K
-7.69%60K
-6.15%61K
-6.15%61K
-15.07%62K
-24.10%63K
Total assets
20.54%38.03M
-47.50%19.13M
-47.50%19.13M
-39.05%23.27M
-34.81%27.74M
56.63%31.55M
55.38%36.45M
55.38%36.45M
46.22%38.17M
41.43%42.56M
Liabilities
Current liabilities
Payables
--3.53M
28.01%2.07M
28.01%2.07M
----
----
----
-3.29%1.62M
-3.29%1.62M
----
----
-accounts payable
--3.53M
28.01%2.07M
28.01%2.07M
----
----
----
-3.29%1.62M
-3.29%1.62M
----
----
Current accrued expenses
--490K
-63.67%793K
-63.67%793K
----
----
----
130.03%2.18M
130.03%2.18M
----
----
Current liabilities
24.47%4.02M
-24.66%2.86M
-24.66%2.86M
34.69%4.03M
25.81%3.7M
50.58%3.23M
44.98%3.8M
44.98%3.8M
27.14%2.99M
-45.92%2.94M
Non current liabilities
Derivative product liabilities
686.98%11.12M
250.63%11.08M
250.63%11.08M
-68.72%613K
-92.06%453K
--1.41M
--3.16M
--3.16M
--1.96M
--5.71M
Other non current liabilities
----
----
----
----
--158K
----
----
----
----
----
Total non current liabilities
686.98%11.12M
250.63%11.08M
250.63%11.08M
-68.72%613K
-89.29%611K
--1.41M
--3.16M
--3.16M
--1.96M
--5.71M
Total liabilities
225.96%15.14M
100.33%13.94M
100.33%13.94M
-6.26%4.64M
-50.19%4.31M
116.39%4.65M
165.55%6.96M
165.55%6.96M
110.51%4.95M
59.16%8.64M
Shareholders'equity
Share capital
11.62%112.65M
0.00%100.92M
0.00%100.92M
0.00%100.92M
-0.05%100.92M
19.24%100.92M
20.62%100.92M
20.62%100.92M
20.76%100.92M
26.10%100.98M
-common stock
11.62%112.65M
0.00%100.92M
0.00%100.92M
0.00%100.92M
-0.05%100.92M
19.24%100.92M
20.62%100.92M
20.62%100.92M
20.76%100.92M
26.10%100.98M
Retained earnings
-31.30%-110.08M
-31.45%-106.45M
-31.45%-106.45M
-19.99%-92.54M
-15.24%-87.57M
-11.66%-83.84M
-14.17%-80.98M
-14.17%-80.98M
-13.88%-77.13M
-20.76%-75.98M
Paid-in capital
6.73%10.44M
12.75%10.7M
12.75%10.7M
9.86%10.21M
14.68%10.05M
17.39%9.78M
19.68%9.49M
19.68%9.49M
20.74%9.29M
20.26%8.76M
Gains losses not affecting retained earnings
-56.76%16K
-66.67%19K
-66.67%19K
-70.15%40K
-81.25%30K
-65.74%37K
-66.67%57K
-66.67%57K
-37.96%134K
-27.27%160K
Other equity interest
--9.86M
----
----
----
----
----
----
----
----
----
Total stockholders'equity
-14.94%22.88M
-82.40%5.19M
-82.40%5.19M
-43.93%18.63M
-30.90%23.44M
49.50%26.9M
41.52%29.49M
41.52%29.49M
39.86%33.23M
37.52%33.92M
Total equity
-14.94%22.88M
-82.40%5.19M
-82.40%5.19M
-43.93%18.63M
-30.90%23.44M
49.50%26.9M
41.52%29.49M
41.52%29.49M
39.86%33.23M
37.52%33.92M
Currency Unit
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 20.31%35.63M-49.45%16.98M-49.45%16.98M-39.82%21.76M-35.80%25.69M53.42%29.62M63.60%33.6M63.60%33.6M54.55%36.15M49.91%40.01M
-Cash and cash equivalents 20.31%35.63M-49.45%16.98M-49.45%16.98M-39.82%21.76M-35.80%25.69M53.42%29.62M63.60%33.6M63.60%33.6M54.55%36.15M139.73%40.01M
Receivables 42.75%1.19M36.14%1.16M36.14%1.16M125.14%403K105.37%306K788.30%835K-34.63%855K-34.63%855K-70.36%179K-65.35%149K
-Taxes receivable --1.19M36.14%1.16M36.14%1.16M-------------34.63%855K-34.63%855K--------
-Other receivables ------------125.14%403K105.37%306K788.30%835K---------70.36%179K-65.35%149K
Prepaid assets 8.20%1.12M-51.86%931K-51.86%931K-41.07%1.05M-27.70%1.69M52.80%1.04M24.94%1.93M24.94%1.93M-12.66%1.78M-19.09%2.34M
Total current assets 20.50%37.94M-47.57%19.08M-47.57%19.08M-39.10%23.21M-34.86%27.68M56.84%31.49M55.55%36.39M55.55%36.39M46.39%38.11M41.61%42.5M
Non current assets
Net PPE --28K------------------------------------
Goodwill and other intangible assets -8.33%55K-6.56%57K-6.56%57K-6.45%58K-6.35%59K-7.69%60K-6.15%61K-6.15%61K-8.82%62K-8.70%63K
-Other intangible assets ------------------59K--60K----------------
Total non current assets 38.33%83K-6.56%57K-6.56%57K-6.45%58K-6.35%59K-7.69%60K-6.15%61K-6.15%61K-15.07%62K-24.10%63K
Total assets 20.54%38.03M-47.50%19.13M-47.50%19.13M-39.05%23.27M-34.81%27.74M56.63%31.55M55.38%36.45M55.38%36.45M46.22%38.17M41.43%42.56M
Liabilities
Current liabilities
Payables --3.53M28.01%2.07M28.01%2.07M-------------3.29%1.62M-3.29%1.62M--------
-accounts payable --3.53M28.01%2.07M28.01%2.07M-------------3.29%1.62M-3.29%1.62M--------
Current accrued expenses --490K-63.67%793K-63.67%793K------------130.03%2.18M130.03%2.18M--------
Current liabilities 24.47%4.02M-24.66%2.86M-24.66%2.86M34.69%4.03M25.81%3.7M50.58%3.23M44.98%3.8M44.98%3.8M27.14%2.99M-45.92%2.94M
Non current liabilities
Derivative product liabilities 686.98%11.12M250.63%11.08M250.63%11.08M-68.72%613K-92.06%453K--1.41M--3.16M--3.16M--1.96M--5.71M
Other non current liabilities ------------------158K--------------------
Total non current liabilities 686.98%11.12M250.63%11.08M250.63%11.08M-68.72%613K-89.29%611K--1.41M--3.16M--3.16M--1.96M--5.71M
Total liabilities 225.96%15.14M100.33%13.94M100.33%13.94M-6.26%4.64M-50.19%4.31M116.39%4.65M165.55%6.96M165.55%6.96M110.51%4.95M59.16%8.64M
Shareholders'equity
Share capital 11.62%112.65M0.00%100.92M0.00%100.92M0.00%100.92M-0.05%100.92M19.24%100.92M20.62%100.92M20.62%100.92M20.76%100.92M26.10%100.98M
-common stock 11.62%112.65M0.00%100.92M0.00%100.92M0.00%100.92M-0.05%100.92M19.24%100.92M20.62%100.92M20.62%100.92M20.76%100.92M26.10%100.98M
Retained earnings -31.30%-110.08M-31.45%-106.45M-31.45%-106.45M-19.99%-92.54M-15.24%-87.57M-11.66%-83.84M-14.17%-80.98M-14.17%-80.98M-13.88%-77.13M-20.76%-75.98M
Paid-in capital 6.73%10.44M12.75%10.7M12.75%10.7M9.86%10.21M14.68%10.05M17.39%9.78M19.68%9.49M19.68%9.49M20.74%9.29M20.26%8.76M
Gains losses not affecting retained earnings -56.76%16K-66.67%19K-66.67%19K-70.15%40K-81.25%30K-65.74%37K-66.67%57K-66.67%57K-37.96%134K-27.27%160K
Other equity interest --9.86M------------------------------------
Total stockholders'equity -14.94%22.88M-82.40%5.19M-82.40%5.19M-43.93%18.63M-30.90%23.44M49.50%26.9M41.52%29.49M41.52%29.49M39.86%33.23M37.52%33.92M
Total equity -14.94%22.88M-82.40%5.19M-82.40%5.19M-43.93%18.63M-30.90%23.44M49.50%26.9M41.52%29.49M41.52%29.49M39.86%33.23M37.52%33.92M
Currency Unit CADCADCADCADCADCADCADCADCADCAD
Audit Opinions ------------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data